Bruno Cassinat (B Cassinat)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 45

Top Venues

Leukemia

American journal of hematology

Blood

Blood advances

Université Paris Diderot (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Université Paris Diderot

France

PHD

Publications

Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology 99 (4) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Marie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, Carine Farkh, Mialitiana Solo Nomenjanahary, Juliette Gay, Stéphane Loyau, Clément Journé, Sébastien Dupont, Véronique Ollivier, Jean-Luc J-L Villeval, Isabelle Plo, Valérie Edmond, Martine Jandrot Perrus, Sylvie Labrouche-Colomer, Bruno Cassinat, Emmanuelle Verger, Jean-Philippe Désilles, Benoît Ho Ho Tin Noé, Aude Triquenot Bagan, Michael Mazighi, Nadine Ajzenberg
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis. Blood advances 8 (12) (2024)
Marie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, Carine Farkh, Mialitiana Solo Nomenjanahary, Juliette Gay, Stéphane Loyau, Clément Journé, Sébastien Dupont, Véronique Ollivier, Jean-Luc J-L Villeval, Isabelle Plo, Valérie Edmond, Martine Jandrot Perrus, Sylvie Labrouche-Colomer, Bruno Cassinat, Emmanuelle Verger, Jean-Philippe Désilles, Benoît Ho Ho Tin Noé, Aude Triquenot Bagan, Michael Mazighi, Nadine Ajzenberg
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis. Blood advances 8 (12) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Kristin Rathje, Nico Gagelmann, Rachel B Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas Thol, Marie Robin, Sofia Oechsler, Michael Heuser, Marie-Thérèse Rubio, Jaroslaw P Maciejewski, Hans Christian Reinhardt, Bart L Scott, Nicolaus Kröger
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation. Bone marrow transplantation 59 (8) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology 99 (4) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology 99 (4) (2024)
Marie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, Carine Farkh, Mialitiana Solo Nomenjanahary, Juliette Gay, Stéphane Loyau, Clément Journé, Sébastien Dupont, Véronique Ollivier, Jean-Luc J-L Villeval, Isabelle Plo, Valérie Edmond, Martine Jandrot Perrus, Sylvie Labrouche-Colomer, Bruno Cassinat, Emmanuelle Verger, Jean-Philippe Désilles, Benoît Ho Ho Tin Noé, Aude Triquenot Bagan, Michael Mazighi, Nadine Ajzenberg
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis. Blood advances 8 (12) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Marie-Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, Carine Farkh, Mialitiana Solo Nomenjanahary, Juliette Gay, Stéphane Loyau, Clément Journé, Sébastien Dupont, Véronique Ollivier, Jean-Luc J-L Villeval, Isabelle Plo, Valérie Edmond, Martine Jandrot Perrus, Sylvie Labrouche-Colomer, Bruno Cassinat, Emmanuelle Verger, Jean-Philippe Désilles, Benoît Ho Ho Tin Noé, Aude Triquenot Bagan, Michael Mazighi, Nadine Ajzenberg
Exacerbation of thrombo-inflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis. Blood advances (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Kristin Rathje, Nico Gagelmann, Rachel B Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas Thol, Marie Robin, Sofia Oechsler, Michael Heuser, Marie-Thérèse Rubio, Jaroslaw P Maciejewski, Hans Christian Reinhardt, Bart L Scott, Nicolaus Kröger
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation. Bone marrow transplantation 59 (8) (2024)
Kristin Rathje, Nico Gagelmann, Rachel B Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas Thol, Marie Robin, Sofia Oechsler, Michael Heuser, Marie-Thérèse Rubio, Jaroslaw P Maciejewski, Hans Christian Reinhardt, Bart L Scott, Nicolaus Kröger
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation. Bone marrow transplantation (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia (2024)
Kristin Rathje, Nico Gagelmann, Rachel B Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas Thol, Marie Robin, Sofia Oechsler, Michael Heuser, Marie-Thérèse Rubio, Jaroslaw P Maciejewski, Hans Christian Reinhardt, Bart L Scott, Nicolaus Kröger
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation. Bone marrow transplantation 59 (8) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology (2024)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia (2023)
Jean-Jacques Kiladjian, Bruno Cassinat
Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies. American journal of hematology (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia (2023)
Jean-Jacques Kiladjian, Bruno Cassinat
MYELOPROLIFERATIVE NEOPLASMS AND SPLANCHNIC VEIN THROMBOSIS: CONTEMPORARY DIAGNOSTIC AND THERAPEUTIC STRATEGIES. American journal of hematology (2023)
Nabih Maslah, Lina Benajiba, Stephane Giraudier, Jean-Jacques Kiladjian, Bruno Cassinat
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape. Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Dikelele Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, Nabih Maslah, Juliette Soret-Dulphy, Emmanuelle Verger, Clémence Marcault, Nathalie Parquet, Pierre Fenaux, Lionel Ades, Emmanuel Raffoux, Stephane Giraudier, Olivier Fain, Bruno Cassinat, Jean-Jacques Kiladjian, Arsenne Mekinian, Lina Benajiba
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID). Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Nico Gagelmann, Anita Badbaran, Rachel B Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas R Thol, Christine Wolschke, Marie Robin, Michael Heuser, Marie-Thérèse Rubio, Jaroslaw P Maciejewski, Hans Christian Reinhardt, Bart L Scott, Nicolaus M Kröger
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood (2023)
Nabih Maslah, Emmanuelle Verger, Stéphane Giraudier, Mathias Chea, Ronald Hoffman, John O Mascarenhas, Bruno Cassinat, Jean-Jacques Kiladjian
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition. Blood advances 6 (9) (2022)
Matthieu Mosca, Gurvan Hermange, Amandine Tisserand, Robert John Noble, Christophe Marzac, Caroline Marty, Cécile Le Sueur, Hugo Campario, Gaëlle Vertenoeil, Mira El-Khoury, Cyril Catelain, Philippe Rameau, Cyril Gella, Julien Lenglet, Nicole Casadevall, Rémi Favier, Eric Solary, Bruno Cassinat, Jean-Jacques Kiladjian, Stefan N Constantinescu, Florence Pasquier, Michael E Hochberg, Hana Raslova, Jean-Luc J-L Villeval, Francois Girodon, William Vainchenker, Paul-Henry Cournede, Isabelle Plo
Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms. Blood 138 (22) (2022)
Nabih Maslah, Yantcha Diawara, Marie Sebert, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
In vitro assessment of the sensitivity to APR-246 + azacitidine combination predicts response to this combination in myelodysplastic/acute myeloid leukaemia patients. British journal of haematology 194 (4) (2021)
Ralfs Buks, Mégane Brusson, Sylvie Cochet, Tatiana Galochkina, Bruno Cassinat, Ivan Nemazanyy, Thierry Peyrard, Jean-Jacques Kiladjian, Alexandre G De Brevern, Slim Azouzi, Wassim El Nemer
ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis. International journal of molecular sciences 22 (7) (2021)
Clémence Marcault, Lin-Pierre Zhao, Nabih Maslah, Emmanuelle Verger, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Marine Cazaux, Nicolas Gauthier, Blandine Roux, Emmanuelle Clappier, Nathalie Parquet, Christine Dosquet, Delphine Rea, Jean-Marc Zini, William Vainchenker, Emmanuel Raffoux, Stéphane Giraudier, Jean-Jacques Kiladjian, Bruno Cassinat, Lina Benajiba
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood 138 (21) (2021)
Emmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, Christine Chomienne, Jean-Jacques Kiladjian, Stephane Giraudier, Bruno Cassinat
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patients. International journal of laboratory hematology 42 (6) (2020)
Nico Gagelmann, Markus Ditschkowski, Rashit Bogdanov, Swann Bredin, Marie Robin, Bruno Cassinat, Rabia Shahswar, Felicitas Thol, Michael Heuser, Gerard Socié, Dietrich Beelen, Ioanna Triviai, Anita Badbaran, Nicolaus Kröger
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. Blood 133 (20) (2019)
Jonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, Sandra Kaiser, Doris Steinemann, Mathijs Arnoud Sanders, Adil S A Hinai, Annelieke Zeilemaker, Sarolta Bojtine Kovacs, Christoph Koellerer, Jenny Ostendorp, Konrad Aumann, Wei Wang, Emmanuel Raffoux, Bruno Cassinat, Lars Bullinger, Brigitte Schlegelberger, Peter J M Valk, Heike Luise Pahl
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood 133 (16) (2019)
Nabih Maslah, Emmanuelle Verger, Marie-Helene Schlageter, Jean-Michel Miclea, Jean-Jacques Kiladjian, Stephane Giraudier, Christine Chomienne, Bruno Cassinat
Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls. Annals of hematology 98 (1) (2018)
Florence Rufflé, Jerome Audoux, Anthony Boureux, Sacha Beaumeunier, Jean-Baptiste Gaillard, Elias Bou Samra, Andre Megarbane, Bruno Cassinat, Christine Chomienne, Ronnie Alves, Sebastien Riquier, Nicolas Gilbert, Jean-Marc Lemaitre, Delphine Bacq-Daian, Anne Laure Bougé, Nicolas Philippe, Therese Commes
New chimeric RNAs in acute myeloid leukemia. F1000Research (2017)
Florence Rufflé, Jerome Audoux, Anthony Boureux, Sacha Beaumeunier, Jean-Baptiste Gaillard, Elias Bou Samra, Andre Megarbane, Bruno Cassinat, Christine Chomienne, Ronnie Alves, Sebastien Riquier, Nicolas Gilbert, Jean-Marc Lemaitre, Delphine Bacq-Daian, Anne Laure Bougé, Nicolas Philippe, Therese Commes
New chimeric RNAs in acute myeloid leukemia. F1000Research 6 (2017)
Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Christine Dosquet, Stephane Giraudier, Marie-Hélène Schlageter, Jean-Christophe Ianotto, Mohammed A Yassin, Nader Al-Dewik, Serge Carillo, Eric Legouffe, Valerie Ugo, Christine Chomienne, Jean-Jacques Kiladjian
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations. Blood 126 (24) (2015)
J-J Kiladjian, S Giraudier, Bruno Cassinat
Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone. Leukemia 30 (4) (2015)
Emmanuelle Verger, France Teillet, Carole Conejero, Gil Letort, Christine Chomienne, Stephane Giraudier, Bruno Cassinat
Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation. British journal of haematology 175 (1) (2015)

Bruno Cassinat.css-eqlu8i{font-size:small;padding-left:4px;} (B Cassinat)

Publication Activity (10 Years)

Top Topics

Top Venues

Bruno Cassinat (B Cassinat)